| Synonyms: | |
| Status: | Approved (1986) |
| Entry Type: | Small molecule |
| Molecule Category: | Parent |
| ATC: | N01AH02 |
| UNII: | 1N74HM2BS7 |
| InChI Key | IDBPHNDTYPBSNI-UHFFFAOYSA-N |
|---|---|
| Smile | |
| InChI |
|
| Property Name | Value |
|---|---|
| Molecular Formula | C21H32N6O3 |
| Molecular Weight | 416.53 |
| AlogP | 1.38 |
| Hydrogen Bond Acceptor | 8.0 |
| Hydrogen Bond Donor | 0.0 |
| Number of Rotational Bond | 9.0 |
| Polar Surface Area | 85.49 |
| Molecular species | NEUTRAL |
| Aromatic Rings | 2.0 |
| Heavy Atoms | 30.0 |
| Targets | EC50(nM) | IC50(nM) | Kd(nM) | Ki(nM) | Inhibition(%) | |
|---|---|---|---|---|---|---|
|
Membrane receptor
Family A G protein-coupled receptor
Peptide receptor (family A GPCR)
Short peptide receptor (family A GPCR)
Opioid receptor
|
- | 15 | - | 8 | 14 |
| Mesh Heading | Maximum Phase | Reference |
|---|---|---|
| Hypoxia | Phase 4 | ClinicalTrials |
| Biliary Tract Diseases; Pancreatic Diseases | Phase 4 | ClinicalTrials |
| Confusion; Digestive System Diseases; Gastrointestinal Diseases | Phase 4 | ClinicalTrials |
| Lung Neoplasms | Phase 4 | ClinicalTrials |
| Emergence Delirium; Psychomotor Agitation | Phase 4 | ClinicalTrials |
| Resources | Reference |
|---|---|
| CAS NUMBER | 71195-58-9 |
| ChEBI | 2569 |
| ChEMBL | CHEMBL634 |
| DrugBank | DB00802 |
| DrugCentral | 114 |
| EPA CompTox | DTXSID9022570 |
| FDA SRS | 1N74HM2BS7 |
| Human Metabolome Database | HMDB0014940 |
| Guide to Pharmacology | 7108 |
| KEGG | C08005 |
| PharmGKB | PA448084 |
| PubChem | 51263 |
| SureChEMBL | SCHEMBL26256 |
| ZINC | ZINC000000601281 |